Plants as sources of natural and recombinant anti-cancer agents

JF Buyel - Biotechnology advances, 2018 - Elsevier
Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

[HTML][HTML] Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B

DS Chen - Journal of hepatology, 2009 - Elsevier
Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people
are chronically infected with the virus. They continue to spread the virus to others and are …

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

LG Rubin, MJ Levin, P Ljungman… - Clinical infectious …, 2014 - academic.oup.com
An international panel of experts prepared an evidenced-based guideline for vaccination of
immunocompromised adults and children. These guidelines are intended for use by primary …

[HTML][HTML] Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine

D Shouval, H Roggendorf, M Roggendorf - Medical microbiology and …, 2015 - Springer
Efficacy and safety of recombinant yeast-derived hepatitis B vaccines for prevention of
hepatitis B have been demonstrated unequivocally worldwide as reflected in reduction in …

[HTML][HTML] Hepatitis B vaccine by intradermal route in non responder patients: an update

M Filippelli, E Lionetti, A Gennaro… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Vaccination is the main prophylactic measure to reduce the mortality caused by hepatitis B
virus (HBV) infection in healthy subjects since the immune response to hepatitis B …

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes

L Lin, B Tan, P Pantapalangkoor, T Ho, AM Hujer… - Vaccine, 2013 - Elsevier
BACKGROUND: The rOmpA vaccine has been shown to protect mice from lethal infection
caused by extreme-drug-resistant (XDR) Acinetobacter baumannii. The role of dose in …

Aktualisierung der S 3-leitlinie zur prophylaxe, diagnostik und therapie der hepatitis-B-virusinfektion

M Cornberg, U Protzer, J Petersen… - Zeitschrift für …, 2011 - thieme-connect.com
Wir möchten darauf hinweisen, dass das Management und die Therapie der chronischen
HBV-Infektion spezielle Kenntnisse erfordert und in der Hand eines in dieser Thematik …

Management of infections in cirrhotic patients: report of a consensus conference

S Fagiuoli, A Colli, R Bruno, P Burra, A Craxì… - Digestive and liver …, 2014 - Elsevier
The statements produced by the consensus conference on infection in end-stage liver
disease promoted by the Italian Association for the Study of the Liver, are here reported. The …

Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-(HBV-) Infektion:„Upgrade” der Leitlinie, AWMF-Register-Nr.: 021/011

M Cornberg, U Protzer, MM Dollinger… - Zeitschrift für …, 2007 - thieme-connect.com
Interessenskonflikte Die Entwicklung von Leitlinien für die medizinische Versorgung
verlangt über die fachliche Expertise hinaus auch eine strikte Vermeidung kommerzieller …

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection

M Cornberg, U Protzer, MM Dollinger… - Zeitschrift für …, 2007 - thieme-connect.com
Conflict of interest While professional expertise is necessary when developing the guideline
for health care, a commercial dependency or other conflict of interest which could influence …